1. Rules for dispensing naloxone hydrochloride.

[PL 2017, c. 364, §6 (RP).]

Terms Used In Maine Revised Statutes Title 32 Sec. 13815

  • Board: means the Maine Board of Pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Collaborative practice agreement: means a written and signed agreement between one or more pharmacists with training and experience relevant to the scope of the collaborative practice and a practitioner that supervises or provides direct consultation to the pharmacist or pharmacists engaging in collaborative drug therapy management that:
A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • dispensing: means the preparation and delivery of a prescription drug in a suitable container appropriately labeled for subsequent administration to or use by a patient or other individual entitled to receive the prescription drug pursuant to a lawful order of a practitioner. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Drug: means :
    • A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Prescription drug order: means a lawful written or oral order of a practitioner for a drug or device. See Maine Revised Statutes Title 32 Sec. 13702-A
    • 2. Rules for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication. The board by rule shall establish standards for authorizing pharmacists to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A?1 and C?1. The rules must establish adequate training requirements and protocols for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication when there is no prescription drug order, standing order or collaborative practice agreement authorizing naloxone hydrochloride or another opioid overdose-reversing medication to be dispensed to the intended recipient. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2?A. A pharmacist authorized by the board pursuant to this subsection to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication may prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A?1 and C?1. An opioid overdose-reversing medication referenced in this subsection must be approved by the federal Food and Drug Administration.

    [PL 2023, c. 161, §8 (AMD).]

    SECTION HISTORY

    PL 2015, c. 508, §5 (NEW). PL 2017, c. 249, §2 (RPR). PL 2017, c. 364, §§6, 7 (AMD). PL 2023, c. 161, §8 (AMD).
      Previous section
    Next section  
     Subchapter 11-A Contents